ID

14481

Beschrijving

Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00895895

Link

https://clinicaltrials.gov/show/NCT00895895

Trefwoorden

  1. 17-04-16 17-04-16 -
Geüploaded op

17 april 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Alzheimer Disease NCT00895895

Eligibility Alzheimer Disease NCT00895895

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of probable alzheimer disease according to the national institute of neurological and communicative disorders and stroke-alzheimer's diseases and related disorders association (nincds-adrda) criteria.
Beschrijving

alzheimers disease; NINCDS-ADRDA Criteria

Datatype

boolean

Alias
UMLS CUI [1]
C0002395
UMLS CUI [2]
C2828081
mini-mental state examination (mmse) score of 12 to 24 at screening
Beschrijving

mini-mental state examination

Datatype

boolean

Alias
UMLS CUI [1]
C0451306
rosen modified hachinski ischemic score < or equal to 4 at screening.
Beschrijving

Modified Hachinski Ischemic Scale

Datatype

boolean

Alias
UMLS CUI [1]
C3826978
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
relevant neurologic disease other than alzheimer disease that may affect cognition or ability to complete the study.
Beschrijving

neurologic disease

Datatype

boolean

Alias
UMLS CUI [1]
C0027765
current major depressive disorder or other current major psychiatric disorder.
Beschrijving

depressive disorder; psychiatric disorder

Datatype

boolean

Alias
UMLS CUI [1]
C0011581
UMLS CUI [2]
C0004936
history of clinically evident stroke or clinically important carotid or vertebrobasilar stenosis or plaque.
Beschrijving

stroke; Carotid Stenosis; vertebrobasilar stenosis; plaque

Datatype

boolean

Alias
UMLS CUI [1]
C0038454
UMLS CUI [2]
C0007282
UMLS CUI [3]
C0149810
UMLS CUI [4]
C0332461
use of prescription or nonprescription medications for cognitive enhancement (including memantine, ginkgo biloba, huperzine a, and cholinesterase inhibitors) within 3 months before the baseline visit.
Beschrijving

memantine; Ginkgo biloba; huperzine a; cholinesterase inhibitors

Datatype

boolean

Alias
UMLS CUI [1]
C0025242
UMLS CUI [2]
C0330206
UMLS CUI [3]
C0063033
UMLS CUI [4]
C0008425

Similar models

Eligibility Alzheimer Disease NCT00895895

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
alzheimers disease; NINCDS-ADRDA Criteria
Item
diagnosis of probable alzheimer disease according to the national institute of neurological and communicative disorders and stroke-alzheimer's diseases and related disorders association (nincds-adrda) criteria.
boolean
C0002395 (UMLS CUI [1])
C2828081 (UMLS CUI [2])
mini-mental state examination
Item
mini-mental state examination (mmse) score of 12 to 24 at screening
boolean
C0451306 (UMLS CUI [1])
Modified Hachinski Ischemic Scale
Item
rosen modified hachinski ischemic score < or equal to 4 at screening.
boolean
C3826978 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
neurologic disease
Item
relevant neurologic disease other than alzheimer disease that may affect cognition or ability to complete the study.
boolean
C0027765 (UMLS CUI [1])
depressive disorder; psychiatric disorder
Item
current major depressive disorder or other current major psychiatric disorder.
boolean
C0011581 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
stroke; Carotid Stenosis; vertebrobasilar stenosis; plaque
Item
history of clinically evident stroke or clinically important carotid or vertebrobasilar stenosis or plaque.
boolean
C0038454 (UMLS CUI [1])
C0007282 (UMLS CUI [2])
C0149810 (UMLS CUI [3])
C0332461 (UMLS CUI [4])
memantine; Ginkgo biloba; huperzine a; cholinesterase inhibitors
Item
use of prescription or nonprescription medications for cognitive enhancement (including memantine, ginkgo biloba, huperzine a, and cholinesterase inhibitors) within 3 months before the baseline visit.
boolean
C0025242 (UMLS CUI [1])
C0330206 (UMLS CUI [2])
C0063033 (UMLS CUI [3])
C0008425 (UMLS CUI [4])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial